【0】Latanoprost: Pediatric drug information

【1】Contributor Disclosures

【2】For abbreviations, symbols, and age group definitions show table

【3】Brand Names: US

【4】*   Iyuzeh;
*   Xalatan;
*   Xelpros

【5】Brand Names: Canada

【6】*   APO-Latanoprost;
*   JAMP Latanoprost;
*   M-Latanoprost;
*   MED-Latanoprost;
*   Monoprost;
*   MYLAN-Latanoprost;
*   RIVA-Latanoprost;
*   SANDOZ Latanoprost;
*   TEVA-Latanoprost;
*   Xalatan

【7】Therapeutic Category

【8】*   Ophthalmic Agent, Antiglaucoma ;
*   Prostaglandin, Ophthalmic

【9】Dosing: Pediatric

【10】Glaucoma, elevated intraocular pressure

【11】**Glaucoma** **, elevated intraocular pressure:** Limited data available: Infants, Children, and Adolescents: Ophthalmic solution (eg, Xalatan): Ophthalmic: 1 drop to affected eye(s) once daily in the evening .

【12】Dosing: Kidney Impairment: Pediatric

【13】There are no dosage adjustments provided in the manufacturer's labeling; however, dosage adjustment unlikely due to low systemic absorption.

【14】Dosing: Hepatic Impairment: Pediatric

【15】There are no dosage adjustments provided in the manufacturer's labeling; however, dosage adjustment unlikely due to low systemic absorption.

【16】Dosing: Adult

【17】Elevated intraocular pressure

【18】**Elevated intraocular pressure:** Ophthalmic: One drop in the affected eye(s) once daily in the evening; do not exceed the once daily dosage (may decrease the IOP-lowering effect)

【19】Dosing: Kidney Impairment: Adult

【20】There is no dosage adjustment provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

【21】Dosing: Hepatic Impairment: Adult

【22】There is no dosage adjustment provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

【23】Adverse Reactions

【24】The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.

【25】\>10%: Ophthalmic: Abnormal sensation in eyes , conjunctival hyperemia , eye discharge , eye irritation , eye pain (≤55%), eye pruritus , foreign body sensation of eye , increased eyelash length , ocular hyperemia , stinging of eyes (≤55%)

【26】1% to 10%:

【27】Dermatologic: Allergic skin reaction (≤1%, including eyelid), skin rash (≤1%)

【28】Infection: Influenza (≤3%)

【29】Neuromuscular & skeletal: Arthralgia (≤1%), back pain (≤1%), myalgia (≤1%)

【30】Ophthalmic: Blepharitis , blurred vision , burning sensation of eyes , conjunctival edema , crusting of eyelid , decreased visual acuity , dry eye syndrome , erythema of eyelid , eyelid edema , eyelid pain , hyperpigmentation of eyelashes , increased eyelash thickness , iris hyperpigmentation , lacrimation , photophobia , punctate keratitis 

【31】Respiratory: Nasopharyngitis (≤3%), upper respiratory tract infection (≤3%)

【32】Postmarketing:

【33】Cardiovascular: Angina pectoris , chest pain, palpitations

【34】Dermatologic: Pruritus, toxic epidermal necrolysis

【35】Gastrointestinal: Nausea, vomiting

【36】Nervous system: Dizziness, headache

【37】Ophthalmic: Conjunctivitis (including pseudopemphigoid of the ocular conjunctiva), corneal edema, corneal erosion, deepening of the eyelid sulcus, herpes simplex keratitis, hyperpigmentation of eyelid, hypertrichosis of eyelid, iris cyst, iritis, keratitis, macular edema (including cystoid macular edema), misdirected growth of eyelashes (including trichiasis), uveitis

【38】Respiratory: Asthma (including exacerbation of asthma), dyspnea

【39】Contraindications

【40】Hypersensitivity to latanoprost, benzalkonium chloride, or any component of the formulation

【41】Warnings/Precautions

【42】**_Concerns related to adverse effects:_**

【43】• Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions, has caused bacterial keratitis.

【44】• Ocular effects: May change/increase brown pigmentation of the iris, the eyelid skin, and eyelashes; length and/or number of eyelashes may also be increased. Pigmentation of the iris is likely to be permanent although iris color change may not be noticeable for months to years; pigmentation of the periorbital tissue and eyelash changes may be reversible following discontinuation of therapy. Long-term consequences and potential injury to eye are not known.

【45】• Ocular inflammation: Intraocular inflammation and exacerbation of inflammation may occur; use with caution in patients with a history of intraocular inflammation (eg, iritis/uveitis) and generally avoid use in patients with active intraocular inflammation.

【46】**_Disease-related concerns:_**

【47】• Herpetic keratitis: Use with caution in patients with a history of herpes simplex keratitis; reactivation may occur. Avoid use in patients with active herpes simplex keratitis.

【48】• Ocular disease: Use with caution in aphakic patients, pseudophakic patients with a torn posterior lens capsule, or patients with risk factors for macular edema. Safety and efficacy have not been determined for use in patients with angle-closure, inflammatory, or neovascular glaucoma.

【49】**_Special populations:_**

【50】• Contact lens wearers: Solution contains benzalkonium chloride which may be absorbed by contact lenses; remove contacts prior to administration and wait 15 minutes before reinserting.

【51】Dosage Forms: US

【52】Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

【53】Emulsion, Ophthalmic:

【54】Xelpros: 0.005%  \[contains edetate (edta) disodium, propylene glycol\]

【55】Solution, Ophthalmic:

【56】Iyuzeh: 0.005%  \[contains edetate (edta) disodium, peg-40 hydrog castor oil(cremophor rh40)\]

【57】Xalatan: 0.005%  \[contains benzalkonium chloride\]

【58】Generic: 0.005% 

【59】Generic Equivalent Available: US

【60】May be product dependent

【61】Pricing: US

【62】**Emulsion** (Xelpros Ophthalmic)

【63】0.005% (per mL): $28.80

【64】**Solution** (Iyuzeh Ophthalmic)

【65】0.005% (per each): $11.96

【66】**Solution** (Latanoprost Ophthalmic)

【67】0.005% (per mL): $3.63 - $38.11

【68】**Solution** (Xalatan Ophthalmic)

【69】0.005% (per mL): $126.86

【70】**Disclaimer:** A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

【71】Dosage Forms: Canada

【72】Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

【73】Solution, Ophthalmic:

【74】Monoprost: 0.005%  \[contains edetate (edta) disodium\]

【75】Xalatan: 0.005%  \[contains benzalkonium chloride\]

【76】Generic: 0.005% 

【77】Administration: Pediatric

【78】Ophthalmic: Wash hands before use.

【79】Solution (eg, Xalatan): Unscrew the cap by turning in the direction of the arrows on top of the cap. Pull lower eyelid down slightly to form a pocket for the eye drop and tilt head back; administer 1 drop. Apply gentle pressure to lacrimal sac immediately following instillation  or instruct patient to gently close eyelid after administration to decrease systemic absorption of ophthalmic drops . Avoid contact of bottle tip with skin or eye; remove contact lenses prior to administration and wait at least 15 minutes after instillation before reinserting soft contact lenses. If more than one topical ophthalmic drug is being used, separate administration by at least 5 minutes.

【80】Administration: Adult

【81】**Ophthalmic:** Wash hands prior to use. May be used with other eye drops to lower intraocular pressure. If more than 1 topical ophthalmic drug is being used, administer the drugs at least 5 minutes apart. Remove contact lenses prior to administration and wait 15 minutes before reinserting.

【82】Storage/Stability

【83】Emulsion: Store at 2°C to 25°C . Protect from light. May be maintained at temperatures up to 40°C  for up to 8 days during shipment.

【84】Solution: Store intact bottles under refrigeration at 2°C to 8°C . Protect from light. May be maintained at temperatures up to 40°C  for up to 8 days during shipment. Once opened, the container may be stored at room temperature up to 25°C  for 6 weeks.

【85】Preservative-free solution: Store unopened foil pouch at 15°C to 25°C . Upon opening the foil pouch, store the single-dose containers at 15°C to 25°C  in the foil pouch; discard unused containers after 30 days. Discard opened single-dose containers immediately after use.

【86】Use

【87】Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension (Iyuzeh \[preservative-free solution\], Xalatan \[solution\], Xelpros \[emulsion\]: FDA approved in adults).

【88】Medication Safety Issues

【89】Sound-alike/look-alike issues:

【90】Latanoprost may be confused with Lantus

【91】Xalatan may be confused with Lantus, Travatan, Xalacom, Zarontin

【92】Metabolism/Transport Effects

【93】None known.

【94】Drug Interactions  

【95】**Note** : Interacting drugs may **not be individually listed below** if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers \[Strong\]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program by clicking on the “Launch drug interactions program” link above.

【96】**Note:** Interacting drugs may **not be individually listed below** if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers \[Strong\]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program

【97】Nonsteroidal Anti-Inflammatory Agents: May diminish the therapeutic effect of Prostaglandins (Ophthalmic). Nonsteroidal Anti-Inflammatory Agents may also enhance the therapeutic effects of Prostaglandins (Ophthalmic). _Risk C: Monitor therapy_

【98】Nonsteroidal Anti-Inflammatory Agents (Ophthalmic): May diminish the therapeutic effect of Prostaglandins (Ophthalmic). Nonsteroidal Anti-Inflammatory Agents (Ophthalmic) may enhance the therapeutic effect of Prostaglandins (Ophthalmic). _Risk C: Monitor therapy_

【99】Prostaglandins (Ophthalmic): The concomitant use of Prostaglandins (Ophthalmic) and Latanoprost may result in increased intraocular pressure. _Risk X: Avoid combination_

【100】Reproductive Considerations

【101】Ophthalmic prostaglandins, such as latanoprost, have a theoretical risk of miscarriage. To decrease this risk, agents other than latanoprost may be preferred for the treatment of glaucoma in patients planning to become pregnant (Strelow 2020).

【102】Pregnancy Considerations

【103】Information related to latanoprost use in pregnancy is limited (DeSantis 2004).

【104】Ophthalmic prostaglandins, such as latanoprost, are generally avoided during pregnancy due to a theoretical risk of miscarriage and premature labor. Agents other than latanoprost may be preferred for the treatment of glaucoma during pregnancy, especially during the first trimester. In general, if ophthalmic agents are needed in pregnancy, the minimum effective dose should be used in combination with punctal occlusion to decrease exposure to the fetus .

【105】Monitoring Parameters

【106】Monitor intraocular pressure; regularly examine patients who develop increased iris pigmentation.

【107】Mechanism of Action

【108】Latanoprost is a prostaglandin F 2 \-alpha analog believed to reduce intraocular pressure by increasing the outflow of the aqueous humor

【109】Pharmacokinetics (Adult Data Unless Noted)

【110】Onset of action: 3 to 4 hours

【111】Peak effect: Maximum: 8 to 12 hours

【112】Absorption: Through the cornea where the isopropyl ester prodrug is hydrolyzed by esterases to the biologically active acid. Peak concentration is reached in 2 hours after topical administration in the aqueous humor.

【113】Distribution: V d : 0.16 ± 0.02 L/kg

【114】Metabolism: Primarily hepatic via fatty acid beta-oxidation

【115】Half-life elimination: 17 minutes

【116】Excretion: Urine (as metabolites)

【117】Brand Names: International

【118】International Brand Names by Country

【119】For country code abbreviations ( show table )  

*   (AE) United Arab Emirates : Loprost | Xalatan ;
*   (AR) Argentina : Gaap ofteno | Gaap ofteno pf | Glaucogesic | Glaucostat | Klonaprost | Latanoflax | Latanoprost dorf | Louten | Ocuprost | Oftal Mix | Oftalpres | Paraiop | Tanamof | Xalatan ;
*   (AT) Austria : Akistan | Arulatan | Glaukodoc | Latacris | Latano Vision | Latanoprost Agepha | Latanoprost Pfizer | Latanoprost Sandoz | Latanoprost stada | Latanoprost unimed | Latanoratio | Xalatan ;
*   (AU) Australia : Apo latanoprost | Chemmart latanoprost | Lanpro | Latanoprost actavis | Latanoprost gh | Latanoprost Pfizer | Latanoprost Sandoz | Terry white chemists latanoprost | Xalaprost | Xalatan ;
*   (BD) Bangladesh : Iprost | Ocuprost | Xalaprost ;
*   (BE) Belgium : Latanoprost Apotex | Latanoprost EG | Latanoprost mylan | Latanoprost noridem | Latanoprost Pfizer | Latanoprost Sandoz | Latanotears | Monoprost | Vizilatan | Xalatan ;
*   (BF) Burkina Faso : Cexolan | Ioprost | Xalatan ;
*   (BG) Bulgaria : Akistan | Glautan | Latalux | Latanoprost actavis | Unilat | Xalatan ;
*   (BR) Brazil : Arulatan | Drenatan | Latanoprosta | Xalatan | Xaloftal ;
*   (CH) Switzerland : Latano Vision | Latanofta | Latanoprost helvepharm | Latanoprost mepha | Latanoprost Pfizer | Latanoprost spirig hc | Xalatan ;
*   (CI) Côte d'Ivoire : Cexolan | Ioprost | Retilys ;
*   (CL) Chile : Gaap ofteno pf | Gaax | Latof | Latof sp | Louten | Monoprost | Tomme | Xalatan ;
*   (CN) China : Sheng ao | Te li jie | Xalatan ;
*   (CO) Colombia : Balanprost | Gaap ofteno | Glaucoftal | Kairos pf | Latanox | Latavital | Louten | Oftidon | Xalatan ;
*   (CZ) Czech Republic : Akistan | Arulatan | Glaucotens | Latalux | Latanoprost actavis | Latanoprost Apotex | Latanoprost olikla | Latanoprost Pos | Latanoprost Ratiopharm | Latanoprost stada | Latanoprost teva | Monopost | Solusin | Unilat | Vizilatan | Xalatan | Xaloptic | Xaloptic neo | Zeleza ;
*   (DE) Germany : Akistan | Arulatan | Emerlatan | Laprost | Latan Ophtal | Latanelb | Latano Q | Latanomed | Latanoprost 1a pharma | Latanoprost abz | Latanoprost actavis | Latanoprost AL | Latanoprost fdc | Latanoprost Hexal | Latanoprost Pfizer | Latanoprost Pos | Latanoprost Ratiopharm | Latanoprost stada | Latanoprost Stulln | Latanoprost Trb | Lifog | Xalatan ;
*   (DO) Dominican Republic : Gaap | Latanox | Latof | Xalatan | Xaloptic ;
*   (EC) Ecuador : Exalo | Gaap | Gaap ofteno pf | Hoprix en ocuvial | Klonaprost | Lanoprost nf | Larsan | Latof | Latof sp | Louten | Vistaclof | Xalatan | Xaloptic | Xenda ;
*   (EE) Estonia : Latanoprost actavis | Latanoprost ntc | Latanoprost Ratiopharm | Latizolil | Unilat | Xalatan | Xaloptic ;
*   (EG) Egypt : Ioprost | Xalatan | Xalatrex ;
*   (ES) Spain : Arulatan | Latanest | Latanoprost actavis | Latanoprost Apotex | Latanoprost arrow | Latanoprost cinfa | Latanoprost combix | Latanoprost kern pharma | Latanoprost Medical mix | Latanoprost Mylan pharmaceuticals | Latanoprost Normon | Latanoprost Qualigen | Latanoprost Ratiopharm | Latanoprost Sandoz | Latanoprost stada | Latanoprost Tarbis | Latanoprost teva | Latanoprost vir | Lifog | Theaprost | Tonlit | Xalatan | Xalavista | Xelor ;
*   (ET) Ethiopia : Latano | Latanostill | Protan ;
*   (FI) Finland : Latanoprost actavis | Latanoprost arrow | Latanoprost Pfizer | Latanoprost Ratiopharm | Latanoprost Sandoz | Oftastad | Xalatan ;
*   (FR) France : Latanoprost actavis | Latanoprost arrow | Latanoprost Biogaran | Latanoprost Chauvin | Latanoprost EG | Latanoprost mylan | Latanoprost Pfizer | Latanoprost Ranbaxy | Latanoprost Sandoz | Latanoprost teva | Latanoprost zentiva | Latanoprost Zydus | Latazed | Monoprost | Vizilatan | Xalatan ;
*   (GB) United Kingdom : Latanoprost arrow | Latanoprost Pfizer | Latanoprost Sandoz | Latanoprost teva | Medizol | Xalatan ;
*   (GR) Greece : Joxar | Latandrops | Lataneau | Latanogan | Lataz | Pharmaprost | Vlepolin | X iop | Xalaprost | Xalatan ;
*   (HK) Hong Kong : Ioprost | Latanoprost Sandoz | Latanoprost toa | Xalatan ;
*   (HR) Croatia : Latanox | Xalatan ;
*   (HU) Hungary : Akistan | Lanotan | Laprosep | Latanoprost actavis | Latanoprost Pfizer | Latapres | Unilat | Vizilatan | Xalatan ;
*   (ID) Indonesia : Lacoma | Lanotan | Latanoprost fahrenheit | Latipress | Xalatan ;
*   (IE) Ireland : Latop | Xalatan | Zanopro ;
*   (IL) Israel : Latano avenir | Xalatan ;
*   (IN) India : 9 pm | Ioprost | Ioptame | Lacoma | Laprost | Latochek | Latodrops | Latoprost | Xalatan ;
*   (IT) Italy : Arulatan | Droplatan | Galaxia | Glak | Iopize | Lastafry | Latacris | Latanoprost actavis | Latanoprost doc generi | Latanoprost EG | Latanoprost mylan | Latanoprost ntc | Latanoprost pensa | Latanoprost rat | Latanoprost Sandoz | Latanoprost sifi | Latanostill | Latay | Macusix | Xalatan | Xalost ;
*   (JO) Jordan : Loprost | Normoprost | Xalatan ;
*   (JP) Japan : Latanoprost Amel | Latanoprost Kissei | Latanoprost Krm | Latanoprost mylan | Latanoprost Nitten | Latanoprost Nitto | Latanoprost NP | Latanoprost ns | Latanoprost Sandoz | Latanoprost Sanwa | Latanoprost Sawai | Latanoprost Senju | Latanoprost Takata | Latanoprost Towa | Latanoprost Wakamoto | Xalatan ;
*   (KE) Kenya : Auroprost rt | Lacoma | Laprost | Latano | Latochek | Latoprost rt | Loprost | Xalatan ;
*   (KR) Korea, Republic of : Lamutan | Lanotan | Lantel | Latano | Lataro | Latast | Monoprost | Nomatan | Ocustan | Optilatan | Optiratan | Optis | Optizaltan | Ostan | Protan | Xalatan | Xalost | Xelano ;
*   (KW) Kuwait : Latano | Xalatan ;
*   (LB) Lebanon : Xalatan ;
*   (LT) Lithuania : Latalux | Latanoprost actavis | Latanoprost elvim | Latanoprost ingen pharma | Latanoprost ntc | Latanoprost Ratiopharm | Latanoprost Sanoswiss | Latizolil | Unilat | Xalatan | Xaloptic ;
*   (LU) Luxembourg : Latanoprost EG | Latanoprost rph | Latanotears | Vizilatan | Xalatan ;
*   (LV) Latvia : Latalux | Latanoprost actavis | Latanoprost ntc | Latanoprost Ratiopharm | Latizolil | Unilat | Xalatan | Xaloptic | Xalvide ;
*   (MA) Morocco : Arulatan | Latano jp | Xalatan ;
*   (MX) Mexico : Ciscotan | Exalo | Gaap ofteno | Kensolub | Kevixkeni | Latanoprost Exakta | Latsol | Lesspio | Outhyp | Procilio st | Rasguna | Sinprein | Xalatan ;
*   (MY) Malaysia : Avetaprost | Ioprost | Latandrops | Latanost | Latanostill | Lataprost | Optaprost | Prosdrop | Xalatan ;
*   (NG) Nigeria : Drulatan | Lataneks | Latanoprost sandoz eyedrop | Xalatan | Xales ;
*   (NL) Netherlands : Latanoprost actavis | Latanoprost bausch&lomb | Latanoprost cf | Latanoprost mylan | Latanoprost Pfizer | Latanoprost Pos | Latanoprost rp | Latanoprost Sandoz | Latanoprost teva | Vizilatan | Xalatan ;
*   (NO) Norway : Glauprost | Latanoprost Sandoz | Monoprost | Xalatan ;
*   (NZ) New Zealand : Hysite | Xalatan ;
*   (PE) Peru : Gaap ofteno | Hoprix | Latanox | Latof | Latof sp | Latoprost | Louten | Vistavit L | Xalacar | Xalaprost | Xalatan | Xaloptic | Xaloptic sr | Zakol ;
*   (PH) Philippines : Astapro | Ioprost | Latadin | Latipress | Xalatan | Xalatrex | Xalavist | Xanoprost ;
*   (PK) Pakistan : Hilatan | Latan | Latep | Prostilet | Xalatan ;
*   (PL) Poland : Akistan | Apo lataprox | Arulatan | Latalux | Latano Pos | Latanoprost arrow | Latanoprost Genoptim | Latanoprost stada | Latanost | Monoprost | Polprost | Rozaprost | Rozaprost mono | Vizilatan | Xalatan | Xalofree | Xaloptic ;
*   (PR) Puerto Rico : Xalatan | Xelpros ;
*   (PT) Portugal : Enicilfree | Latanoprost actavis | Latanoprost Ciclum | Latanoprost edol | Latanoprost farmoz | Latanoprost generis | Latanoprost germed | Latanoprost pentafarma | Latanoprost Sandoz | Latanoprost teva | Xalatan ;
*   (PY) Paraguay : Glaucogesic | Lanoprost | Latanoflax | Latof | Louten ;
*   (QA) Qatar : Loprost | Xalatan ;
*   (RO) Romania : Arulatan | Glautan | Sifitan | Unilat | Xalatan | Xaloptic ;
*   (RU) Russian Federation : Glaumax | Glauprost | Lanotan | Latanomol | Latanoprost dia | Latanoprost optic | Latanoprost teva | Prolatan | Trilaktan | Xalatamax | Xalatan ;
*   (SA) Saudi Arabia : Latano | Lataprost | Xalatan ;
*   (SE) Sweden : Latanoprost actavis | Latanoprost arrow | Latanoprost bijon | Latanoprost orifarm | Latanoprost Sandoz | Latanoprost stada | Latanoprost teva | Xalatan ;
*   (SG) Singapore : Xalatan ;
*   (SI) Slovenia : Latanox | Xalatan ;
*   (SK) Slovakia : Akistan | Arulatan | Latalux | Latanoprost actavis | Latanoprost olikla | Solusin | Tiopromal | Unilat | Xalatan | Xaloptic ;
*   (TH) Thailand : Lanotan | Lumoprost | Xalaprost | Xalatan | Xaprost ;
*   (TN) Tunisia : Lata sp | Latanocol | Latapol | Lataz | Xalatan ;
*   (TR) Turkey : Glokoprost | Latapol | Latasopt | Latrost | Pegea | Xalatan ;
*   (TW) Taiwan : Latan | Unitan | Xalaprost | Xalatan ;
*   (UA) Ukraine : Akistan | Glaumax | Lanotan | Lapronext | Latanox | Latasopt | Prolatan | Xalatan ;
*   (UG) Uganda : Auroprost rt | Xalatan ;
*   (UY) Uruguay : Gaap ofteno | Latof | Louten | Vistaclof | Xalatan ;
*   (VE) Venezuela, Bolivarian Republic of : Gaap ofteno | Laprost | Latacof | Latanopress | Latanox | Latros | Xalatan | Xaloptic ;
*   (ZA) South Africa : Atana | Ioprost | Ocuprost | Spersatan | Xalatan ;
*   (ZM) Zambia : Lacoma | Xalatan ;
*   (ZW) Zimbabwe : Xalatan焦瀚远

====================================================================================================
